NICHOLE SNOW: Open Payments
NPI 1538239587 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,367 in 50 payments from 16 companies in 2025. Trend: 2023 $5,596 · 2024 $1,487 · 2025 $1,367
Food & beverage: $1,367
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $313 |
| AstraZeneca Pharmaceuticals LP | 5 | $180 |
| ABIOMED | 5 | $174 |
| AtriCure, Inc. | 1 | $98 |
| Lilly USA, LLC | 5 | $96 |
| Dexcom, Inc. | 3 | $92 |
| PFIZER INC. | 5 | $87 |
| ABBVIE INC. | 3 | $66 |
| Novo Nordisk Inc | 4 | $59 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $53 |
Products named: REPATHA, FARXIGA, EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, Dexcom G6 Transmitter, Kerendia, MOUNJARO, Ozempic, AIRSUPRA.
Industry payments across SC — which companies pay providers there.
